Showing all posts written by Casey Donahoe

Casey Donahoe
Casey Donahoe
BioArctic Announces Patent Allowance Entitled Spinal Cord Devices and Methods for Promoting Axonal Regeneration

BioArctic Announces Patent Allowance Entitled Spinal Cord Devices and Methods for Promoting Axonal Regeneration

BioArctic AB, a public Swedish biopharma company, recently announced that they received allowance of a patent application directed to a method of promoting axonal regeneration using a biodegradable spinal cord device. The medical device

Takeda Pharmaceuticals Explores GI Devices in New Partnership with Nanotechnology Company

Takeda Pharmaceutical Company, a Japan-based global pharmaceutical company, recently announced an agreement with BioSurfaces Inc., a small Massachusetts research company, to research the development of medical devices for the treatment

Johnson & Johnson’s Codman Neuro Announces Acquisition of Neuravi

Johnson & Johnson’s Codman Neuro Announces Acquisition of Neuravi

Codman Neuro, part of Johnson & Johnson’s DePuy Synthes business unit, recently announced its acquisition of Neuravi Ltd., a privately-held Irish medical device company, for an undisclosed amount.  The Irish Times reported that